Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy-Reference-Cited by-同舟云学术

Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy

Published:2015-10-13 Issue:3 Volume:21 Page:498-505
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Iioka Futoshi,Izumi Kiyotaka,Kamoda Yoshimasa,Akasaka Takashi,Ohno Hitoshi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-015-0912-6.pdf

Reference27 articles.

1. Stein H, Chan JKC, Warnke RA et al (2008) Diffuse large B-cell lymphoma, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 233–237

2. National Cancer Institute (2014) SEER cancer statistics review 1975–2011. http://seer.cancer.gov/csr/1975_2011/browse_csr.php?sectionSEL=19&pageSEL=sect_19_table.27.html

3. Ministry of Health, Labour and Welfare (2013) Handbook of health and welfare statistics. http://www.mhlw.go.jp/toukei/saikin/hw/life/life13/index.html

4. Statistics Bureau (2015) Japan statistical yearbook. http://www.stat.go.jp/english/data/nenkan/1431-02.htm

5. Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235–242

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evaluation based on relative treatment intensity in older patients treated with reduced-dose R-THP-COP therapy for diffuse large B-cell lymphoma: A multicenter retrospective cohort study;Journal of Geriatric Oncology;2023-01

2. Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment – A systematic review;Critical Reviews in Oncology/Hematology;2021-04

3. A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapy;Leukemia & Lymphoma;2020-05-25

4. Treatment approaches for older and oldest patients with diffuse large B-cell lymphoma – Use of non-R-CHOP alternative therapies and impact of comorbidities on treatment choices and outcome: A Humedica database retrospective cohort analysis, 2007–2015;Journal of Geriatric Oncology;2020-01

5. Adjusted Chemotherapy According to Frailty Status in Elderly Patients With Diffuse Large B-Cell Lymphoma: Experience From a Single Referral Center in Mexico City;Clinical Lymphoma Myeloma and Leukemia;2019-02